Fumarylacetoacetic acid

Fumarylacetoacetic acid is a key intermediate in the metabolic pathway known as phenylalanine and tyrosine catabolism. It plays a crucial role in the breakdown and utilization of these amino acids, which are vital components of proteins. The metabolism of phenylalanine and tyrosine is essential for the production of energy and the synthesis of several important molecules, including neurotransmitters and hormones.

Biochemistry

Fumarylacetoacetic acid is formed through the enzymatic modification of 4-hydroxyphenylpyruvate, a step that involves the action of the enzyme 4-hydroxyphenylpyruvate dioxygenase. This conversion is part of the tyrosine degradation pathway, which is critical for preventing the accumulation of toxic substances in the body and for generating acetoacetate and fumarate, both of which can enter the Krebs cycle for energy production.

The next step in the pathway involves the enzyme fumarylacetoacetase (also known as FAH), which catalyzes the hydrolysis of fumarylacetoacetic acid to fumarate and acetoacetate. This reaction is not only crucial for energy production but also for the synthesis of ketone bodies, which are important energy sources during fasting states.

Clinical Significance

A deficiency in the enzyme fumarylacetoacetase leads to a metabolic disorder known as Tyrosinemia type I. This condition results in the accumulation of fumarylacetoacetic acid and other toxic metabolites in the body, causing severe liver and kidney damage, and if untreated, can be fatal. Tyrosinemia type I is a genetic disorder, inherited in an autosomal recessive pattern, and highlights the importance of fumarylacetoacetic acid in human metabolism and disease.

Treatment and Management

The management of Tyrosinemia type I involves the use of nitisinone, a drug that inhibits the enzyme 4-hydroxyphenylpyruvate dioxygenase, thereby reducing the formation of fumarylacetoacetic acid and its toxic metabolites. Dietary restriction of phenylalanine and tyrosine is also recommended to decrease their intake and subsequent metabolism. Liver transplantation may be considered in severe cases where liver damage is extensive.

See Also

• Amino acid metabolism
• Metabolic disorder
• Krebs cycle
• Liver transplantation

References

• 
  Fumarylacetoacetic acid